ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 12 out of 1448

$1.67M Total Retail Price of All Prescriptions

Rank: 11 out of 1448

1,063 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 20,906 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$77 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ISOSORBIDE MONONITRATE ER 1,681 1,623 10 1 16
AMLODIPINE BESYLATE 1,431 1,398 2 2
DOXAZOSIN MESYLATE 1,002 983 10 3 65
BYSTOLIC 909 898 4 32
CRESTOR 824 798 5 17
ATORVASTATIN CALCIUM 762 744 6 4
PRAVASTATIN SODIUM 758 736 7 20
DIOVAN 706 687 8 15
METOPROLOL SUCCINATE 703 680 9 6
CARVEDILOL 648 616 10 1
CLOPIDOGREL 557 525 11 10
PLAVIX 526 516 12 14
BENICAR 488 452 13 50
WARFARIN SODIUM 436 401 14 8
BENAZEPRIL HCL 432 424 15 26
BISOPROLOL FUMARATE 431 410 16 72
ATENOLOL 393 375 17 12
AMLODIPINE BESYLATE-BENAZEPRIL 328 324 18 67
LOSARTAN POTASSIUM 302 293 19 11
LOVASTATIN 287 268 20 35
RANEXA 281 266 21 37
TRICOR 278 274 22 94
AZOR 277 273 23 125
FUROSEMIDE 272 264 24 7
ZETIA 257 235 25 28
METOPROLOL TARTRATE 237 206 26 9
EXFORGE 232 227 27 80
AMIODARONE HCL 227 226 28 22
LOVAZA 225 225 29 39
BISOPROLOL-HYDROCHLOROTHIAZIDE 216 195 30 152
DIOVAN HCT 211 211 31 29
FLECAINIDE ACETATE 211 199 31 53
TRILIPIX 210 200 33 86
BENICAR HCT 198 195 34 84
LISINOPRIL 183 155 35 5
NITROSTAT 177 158 36 31
HYDRALAZINE HCL 165 161 37 44
FENOFIBRATE 160 150 38 54
TEKTURNA 160 160 38 106
MULTAQ 158 156 40 57
LIPITOR 157 157 41 30
SIMVASTATIN 154 142 42 3
HYDROCHLOROTHIAZIDE 145 138 43 18
LOSARTAN-HYDROCHLOROTHIAZIDE 140 129 44 38
DIGOXIN 124 113 45 13
FELODIPINE ER 124 121 45 133
RAMIPRIL 95 90 47 36
GUANFACINE HCL 85 85 R 48 199
OMEPRAZOLE 85 85 48 23
DILTIAZEM 24HR CD 85 84 48 61
ZOLPIDEM TARTRATE 82 82 51 34
GLYBURIDE-METFORMIN HCL 78 78 R 52 132
TAMSULOSIN HCL 77 77 53 46
BENAZEPRIL-HYDROCHLOROTHIAZIDE 76 75 54 182
TEKTURNA HCT 68 68 55 275
ENALAPRIL MALEATE 62 62 56 48
METFORMIN HCL 60 60 57 25
GABAPENTIN 60 60 57 51
SOTALOL 59 49 59 40
WELCHOL 58 53 60 103
TRANDOLAPRIL 56 56 61 298
ALLOPURINOL 52 52 62 43
METOCLOPRAMIDE HCL 51 51 63 190
ACARBOSE 51 43 63 210
PANTOPRAZOLE SODIUM 50 50 65 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 5, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.